Correlation Between Apogee Therapeutics, and Nuvalent

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Nuvalent, you can compare the effects of market volatilities on Apogee Therapeutics, and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Nuvalent.

Diversification Opportunities for Apogee Therapeutics, and Nuvalent

0.39

Correlation Coefficient

Apogee Therapeutics,  Nuvalent

Weak diversification

The 3 months correlation between Apogee and Nuvalent is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Nuvalent go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Nuvalent

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Nuvalent. In addition to that, Apogee Therapeutics, is 1.68 times more volatile than Nuvalent. It trades about -0.03 of its total potential returns per unit of risk. Nuvalent is currently generating about -0.02 per unit of volatility. If you would invest  7,787  in Nuvalent on December 29, 2024 and sell it today you would lose (425.00) from holding Nuvalent or give up 5.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Nuvalent

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Nuvalent

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Nuvalent is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Apogee Therapeutics, and Nuvalent

The main advantage of trading using opposite Apogee Therapeutics, and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.

The idea behind Apogee Therapeutics, Common and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.